Skip to search formSkip to main contentSkip to account menu

Vivitrol

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Abstract Introduction: Amfetamine and methamfetamine abuse remains a prevalent health problem, increasing the burden on… 
2019
2019
Objective: To determine the efficacy and tolerability of a long-acting intramuscular formulation of Nalmefene (Nalmefene Consta… 
2018
2018
AIM To evaluate the efficacy of treatment of patients at risk of deprivation of parental rights due to alcohol dependence under… 
Review
2018
Review
2018
Background and Objectives Opioid use disorder (OUD) is a chronic condition with potentially severe health and social consequences… 
Highly Cited
2015
Highly Cited
2015
BACKGROUND AND AIMS Relapse to addiction following incarceration is common. We estimated the feasibility and effectiveness of… 
2015
2015
BACKGROUND Pharmacotherapy studies involving buprenorphine have rarely been conducted with U.S. community corrections populations… 
2013
2013
This article presents the results of a study of clinical features of the development and course of alcohol dependence in patients… 
Review
2013
Review
2013
Naltrexone is a μ-opioid receptor antagonist that blocks the euphoric effects of heroin and prescription opioids. In order to… 
Review
2008
Review
2008
Coerced or involuntary treatment comprises an integral, often positive component of treatment for addictive disorders. By the… 
2007
2007
While oral naltrexone has a demonstrated ability to decrease alcohol reinforcement, it also has pharmacotherapeutic limitations…